Additionally, a stratified survival analysis showed that a high serum CRP level was a predictor for RFS in both stage I/II cancers (P = 0.007, Kaplan-Meier Method) (Fig. 2e) and stage III/IV cancers (P = 0. Here, CRP is linked to cancer.